SCHEMBL13488649

SCHEMBL13488649

CC(=O)Nc1cccc(OO)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.59
MTNR1B P49286 2/20 0.59
ALDH1A1 P00352 2/20 0.59
CYP1A2 P05177 1/20 0.59
HSD17B10 Q99714 1/20 0.59
RAB9A P51151 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
NPC1 O15118 1/20 0.59
TSHR P16473 1/20 0.56
GAA P10253 2/20 0.56
AHR P35869 1/20 0.55
POLB P06746 1/20 0.54
NR4A1 P22736 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
KDM4E B2RXH2 1/20 0.54
CRHBP P24387 1/20 0.54
HTT P42858 1/20 0.54
CRHR2 Q13324 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12888865 0.86 MAPK1 (0.65) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL29875454 0.85 MTNR1A (0.79) MTNR1AMTNR1BALDH1A1RAB9ASMN1; SMN2
SCHEMBL14338249 0.85 MTNR1B (0.69) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL171425 0.85 MTNR1A (0.79) MTNR1AMTNR1BALDH1A1RAB9ASMN1; SMN2
SCHEMBL9162294 0.84 MTNR1B (0.77) MTNR1AMTNR1BALDH1A1HSD17B10RAB9A
SCHEMBL2534228 0.84 GAA (0.58) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL16215583 0.84 MTNR1A (0.58) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL359762 0.84 MEN1 (0.71) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL1886748 0.82 MTNR1A (0.56) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10
SCHEMBL11546092 0.82 SMN1; SMN2 (0.68) MTNR1AMTNR1BALDH1A1CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048891-A1 METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG SCHULZE KLAUSE 2010-02-25 US disclosed
US-20070015759-A1 Metasubstituted thiazolidinones, their manufacture and use as a drug BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048891-A1 METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG PLK2, PDXK, PLK4 MTNR1A 2809/4885MTNR1B 2372/4885ALDH1A1 1600/4885
US-20070015759-A1 Metasubstituted thiazolidinones, their manufacture and use as a drug PLK4, PDXK, PLK2 MTNR1A 2224/4885MTNR1B 1759/4885ALDH1A1 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.